Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
European Journal of Radiology
|
April 29, 2023
Prognostic value of [<sup>18</sup>F]FDG PET/CT on treatment response and progression-free survival of gastroesophageal cancer patients undergoing perioperative FLOT chemotherapy
Seyed Ali Mirshahvalad, Seyedeh Sara Seyedinia, Florian Huemer, et al.
BMC Cancer
|
December 24, 2015
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer
Florian Huemer, Thomas Melchardt, Wolfgang Tränkenschuh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI
Thomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Technology in Cancer Research & Treatment
|
May 20, 2024
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer Patients
Thomas Parigger, Franz Josef Gassner, Stephan Drothler, et al.
Cancers
|
November 26, 2022
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy
Falk Roeder, Sabine Gerum, Stefan Hecht, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 27, 2021
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition
Florian Kocher, Piotr Tymoszuk, Arno Amann, et al.
Cancers
|
February 10, 2021
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
Teresa Magnes, Sandro Wagner, Aaron R Thorner, et al.
Journal of Clinical Medicine
|
June 5, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, et al.
Wiener Klinische Wochenschrift
|
September 16, 2021
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT
Teresa Magnes, Sandro M Wagner, Thomas Melchardt, et al.
European Journal of Haematology
|
February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM
Florian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
European Journal of Radiology
|
April 29, 2023
Prognostic value of [<sup>18</sup>F]FDG PET/CT on treatment response and progression-free survival of gastroesophageal cancer patients undergoing perioperative FLOT chemotherapy
Seyed Ali Mirshahvalad, Seyedeh Sara Seyedinia, Florian Huemer, et al.
BMC Cancer
|
December 24, 2015
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer
Florian Huemer, Thomas Melchardt, Wolfgang Tränkenschuh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2015
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI
Thomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Technology in Cancer Research & Treatment
|
May 20, 2024
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer Patients
Thomas Parigger, Franz Josef Gassner, Stephan Drothler, et al.
Cancers
|
November 26, 2022
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy
Falk Roeder, Sabine Gerum, Stefan Hecht, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 27, 2021
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition
Florian Kocher, Piotr Tymoszuk, Arno Amann, et al.
Cancers
|
February 10, 2021
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
Teresa Magnes, Sandro Wagner, Aaron R Thorner, et al.
Journal of Clinical Medicine
|
June 5, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, et al.
Wiener Klinische Wochenschrift
|
September 16, 2021
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT
Teresa Magnes, Sandro M Wagner, Thomas Melchardt, et al.
European Journal of Haematology
|
February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM
Florian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Page
of 5